Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3155686rdf:typepubmed:Citationlld:pubmed
pubmed-article:3155686lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:3155686lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:3155686lifeskim:mentionsumls-concept:C0022688lld:lifeskim
pubmed-article:3155686lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:3155686lifeskim:mentionsumls-concept:C0013485lld:lifeskim
pubmed-article:3155686lifeskim:mentionsumls-concept:C0024348lld:lifeskim
pubmed-article:3155686lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:3155686pubmed:issue1lld:pubmed
pubmed-article:3155686pubmed:dateCreated1985-3-14lld:pubmed
pubmed-article:3155686pubmed:abstractTextH-2-lacking murine embryonal carcinoma (EC) cells have been proposed as universal targets for natural killer (NK) effectors from different species because their killing appeared to be uncomplicated by potential T cell effector mechanisms (Stern, P. L. et al., Int. J. Cancer 1981. 27:679). While some previous studies had shown that murine cytotoxic T cells were unable to lyse EC cells, rat T killers are shown here to be active against these targets and to be distinguishable from NK cells. Percoll density fractionation of rat peripheral blood lymphocytes enriches in parallel for NK-mediated lysis of both EC or YAC target cells. These NK cells unlike T cells, do not mediate lectin-dependent and cell-mediated cytotoxicity (LDCC) of NK-insensitive target cells. This procedure is thought to reveal the total cytolytic potential of stimulated T cell populations, regardless of specificity. In contrast to previous results with mice, we found that allogeneically primed rat cytotoxic T cells can kill murine EC cells in LDCC and, further, that rat cytotoxic T cells, generated by stimulation with mouse spleen cells in vitro, can lyse murine EC cells directly. This demonstration of T cell lysis of EC cells suggests that either there is a novel mechanism of lysis operating without requirement for major histocompatibility complex (MHC) structures, or EC cells express some hitherto unidentified MHC-like structures on their cell surface.lld:pubmed
pubmed-article:3155686pubmed:languageenglld:pubmed
pubmed-article:3155686pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3155686pubmed:citationSubsetIMlld:pubmed
pubmed-article:3155686pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3155686pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3155686pubmed:statusMEDLINElld:pubmed
pubmed-article:3155686pubmed:monthJanlld:pubmed
pubmed-article:3155686pubmed:issn0014-2980lld:pubmed
pubmed-article:3155686pubmed:authorpubmed-author:BellS MSMlld:pubmed
pubmed-article:3155686pubmed:authorpubmed-author:SternP LPLlld:pubmed
pubmed-article:3155686pubmed:issnTypePrintlld:pubmed
pubmed-article:3155686pubmed:volume15lld:pubmed
pubmed-article:3155686pubmed:ownerNLMlld:pubmed
pubmed-article:3155686pubmed:authorsCompleteYlld:pubmed
pubmed-article:3155686pubmed:pagination59-65lld:pubmed
pubmed-article:3155686pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:meshHeadingpubmed-meshheading:3155686-...lld:pubmed
pubmed-article:3155686pubmed:year1985lld:pubmed
pubmed-article:3155686pubmed:articleTitleRat natural killer cell and cytotoxic T cell lysis of H-2-negative murine embryonal carcinoma cells.lld:pubmed
pubmed-article:3155686pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3155686pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3155686lld:pubmed